Thrombotic Microangiopathy and the Kidney
Author(s) -
Vicky Brocklebank,
Katrina M. Wood,
David Kavanagh
Publication year - 2017
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.00620117
Subject(s) - thrombotic microangiopathy , medicine , microangiopathic hemolytic anemia , microangiopathy , intensive care medicine , pathogenesis , epidemiology , acute kidney injury , schistocyte , pathology , gastroenterology , thrombotic thrombocytopenic purpura , platelet , diabetes mellitus , disease , endocrinology
Thrombotic microangiopathy can manifest in a diverse range of diseases and is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and organ injury, including AKI. It can be associated with significant morbidity and mortality, but a systematic approach to investigation and prompt initiation of supportive management and, in some cases, effective specific treatment can result in good outcomes. This review considers the classification, pathology, epidemiology, characteristics, and pathogenesis of the thrombotic microangiopathies, and outlines a pragmatic approach to diagnosis and management.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom